COMPANY PROFILE

HOME BIOSCIENCES

Explore full profile

Home Biosciences:generating life changing medicines for patients

Paris, FranceFounded 2019Biotech & Life Sciences

Valuation $50–100M Last recorded · 2021

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About HOME BIOSCIENCES

Home Biosciences is a biotechnology company focused on developing transformative medicines for patients who have limited or no therapeutic options. The company operates in the pharmaceutical and biotechnology markets, targeting unmet medical needs through innovative scientific and technological advancements. Home Biosciences collaborates with academics and scientists to create agile, dedicated ventures staffed with highly skilled execution teams. The business model revolves around identifying, creating, and advancing breakthrough therapies, providing adequate financing and support to project teams to ensure full focus and alignment of interests. Revenue is generated through the development and commercialization of these novel therapies, as well as potential partnerships and licensing agreements with other pharmaceutical companies.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2019
Headquarters: Paris, France
Employees: 1
Open positions: None listed
Dealroom signal: 57.3/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, Woman Founder, DT and LS, observatoire healthtech, observatoire ia, science-based
Business model: Manufacturing
Client focus: b2b
Investment activity: 1 company, latest Sep 2022
Capital deployed: $7.7M
Preferred round: SERIES A
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SEED✓Equity / VC	Nov 2021	$17M	$66M	Sofinnova Partners · Redmile Group	—

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

HOME BIOSCIENCES website traffic

Latest recorded traffic for HOME BIOSCIENCES is 130 monthly website visits, up 160% over the last three months. HOME BIOSCIENCES's team declined 50% over the past year.

Latest monthly visits130 3-month web change+160% 1-year team growth-50%

Monthly website visitsApr 2022–Jun 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
OBOne BiosciencesOperating a ‘discovery engine’ leveraging single-cell technologies to identify new therapeutics for difficult-to-treat diseases	Paris, France	Operational	43	$24M	$66M
ODOdimmaFrench biotech company with a unique approach in active personalized cancer immunotherapy	Illkirch, France	Operational
THTHERAPANACEADevotion to Innovation, Compassion for Patients, Artificial Intelligence for Cancer Care	Paris, France	Operational
HPHcs PharmaA company specializing in cell imaging	Loos, France	Operational
ENEncefaDevelops biologics that specifically modulate a key age-related target, to fight neurodegenerative, auto-immune, and more broadly age-related diseases	Paris, France	Operational
LYLYSOGENEClinical stage biotechnology company pioneering in the basic research and clinical development of AAV gene therapy for CNS disorders with a high unmet medical need	Neuilly-sur-Seine, France	Operational
CICiloaDedicated to the production of fully native membrane proteins on exosomes	Montpellier, France	Operational
LHLegacy HealthcareBiopharma developing innovative botanical drugs in supportive oncology care and dermatology	Epalinges, Switzerland	Operational